Soluble Fibrin for Diagnosing Pulmonary Embolism (SOFIE)
Evaluation of Performances of Soluble Fibrin Assay for Diagnosing Pulmonary Embolism
Sponsor: Diagnostica Stago R&D
Listed as NCT02438462, this observational or N/A phase trial focuses on Pulmonary Embolism (PE) and remains completed. Sponsored by Diagnostica Stago R&D, it has been updated 13 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
▶ Show 8 earlier versions
-
May 2019 — Nov 2020 [monthly]
Completed
Status: Unknown Status → Completed
-
Apr 2019 — May 2019 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jun 2018 — Apr 2019 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Apr 2017 — Aug 2017 [monthly]
Recruiting NA
-
Jan 2017 — Apr 2017 [monthly]
Recruiting NA
First recorded
Jun 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Diagnostica Stago R&D
- European Georges Pompidou Hospital
For direct contact, visit the study record on ClinicalTrials.gov .